Literature DB >> 4856590

Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine.

D C Speller.   

Abstract

Two diabetic patients with symptomatic urinary tract infection by Torulopsis glabrata were successfully treated with two-week courses of 5-fluorocytosine.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4856590      PMCID： PMC477985          DOI： 10.1136/jcp.27.1.50

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  12 in total

1.  5-fluorocytosine treatment of candida infections of the urinary tract and other sites.

Authors:  J Schönebeck; L Steen; A Tärnvik
Journal:  Scand J Urol Nephrol       Date:  1972

2.  Sensitivity of yeasts to 5-fluorocytosine.

Authors:  D C Speller; M G Davies
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

3.  Torulopsis glabrata septicaemia treated with 5-fluorocytosine.

Authors:  A J Webb; D C Speller; K G Buckler
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

4.  5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.

Authors:  P L Steer; M I Marks; P D Klite; T C Eickhoff
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

5.  Torulopsis glabrata--an opportunistic pathogen in man.

Authors:  M I Marks; C Langston; T C Eickhoff
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

6.  5-fluorocytosine and urinary candidiasis.

Authors:  R R Davies; D S Reeves
Journal:  Br Med J       Date:  1971-03-13

7.  Urinary tract infection with Torulopsis glabrata treated by alkalization of urine.

Authors:  L Edebo; A Spetz
Journal:  Br Med J       Date:  1965-10-23

8.  Speciation and densities of yeasts in human urine specimens.

Authors:  D G Ahearn; J R Jannach; F J Roth
Journal:  Sabouraudia       Date:  1966-10

9.  The antimycotic activity of 5-fluorocytosine.

Authors:  R J Holt; R L Newman
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

10.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06
View more
  2 in total

Review 1.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 2.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.